Viking Therapeutics, Inc. (VKTX) /
The profitability of Viking Therapeutics, Inc. over the past 10 years
Chart Viking Therapeutics, Inc.: operating income, net income, fiscal 2016–2025 Open the chart →Viking Therapeutics, Inc. reported a net loss of $359.64M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $393.34M. It reported a loss in all 10 years shown.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$393.34M | -$359.64M |
| 2024ended Dec 31, 2024 | -$150.92M | -$109.96M |
| 2023ended Dec 31, 2023 | -$100.83M | -$85.89M |
| 2022ended Dec 31, 2022 | -$70.36M | -$68.87M |
| 2021ended Dec 31, 2021 | -$55.68M | -$54.99M |
| 2020ended Dec 31, 2020 | -$42.66M | -$39.49M |
| 2019ended Dec 31, 2019 | -$32.69M | -$25.78M |
| 2018ended Dec 31, 2018 | -$26.16M | -$22.06M |
| 2017ended Dec 31, 2017 | -$19.07M | -$20.58M |
| 2016ended Dec 31, 2016 | -$13.85M | -$14.73M |
Fiscal years as Viking Therapeutics, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Viking Therapeutics, Inc.
- The revenue of Viking Therapeutics, Inc.
- The debt of Viking Therapeutics, Inc.
- All of Viking Therapeutics, Inc.'s financials, charted
Companies of a similar size
- DRHDIAMONDROCK HOSPITALITY CO
- GLXYGalaxy Digital Inc.
- ARCBARCBEST CORPORATION
- KNKnowles Corporation
- COTYCOTY INC.
Not investment advice. This page shows what Viking Therapeutics, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.